This is a citizen science site -- you can contribute by investing and sharing your time.
Common knowledge amoung some professionals (MD and ND):
Vitamin D: There is some research suggesting that maintaining adequate vitamin D levels might support the immune system and overall health, potentially reducing the risk of severe respiratory infections. However, its specific role in Long COVID management is not fully established.
Omega-3 Fatty Acids: Omega-3 fatty acids from sources like fish oil may have anti-inflammatory properties that could potentially benefit individuals with Long COVID, particularly for symptoms related to inflammation.
Probiotics: While not specific to Long COVID, maintaining gut health through probiotics might have an indirect positive impact on overall health and immune function. A healthy gut microbiome could potentially aid in immune regulation and reduce inflammation, although its direct effect on Long COVID is yet to be established.
Multivitamins and Minerals: Ensuring adequate intake of essential vitamins and minerals through a balanced diet or supplements may support overall health, but their specific role in managing Long COVID requires further research.
The Studies below identify bacteria. Check if it has already been reviewed.
| 1 | 📚 |
Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Gastroenterology (Gastroenterology ) Vol: 159 Issue: 4 Pages: 1302-1310.e5 Pub: 2020 Oct ePub: 2020 Jun 26 Authors Zuo T,Zhan H,Zhang F,Liu Q,Tso EYK,Lui GCY,Chen N,Li A,Lu W,Chan FKL,Chan PKS,Ng SC |
| 2 | 📚 |
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Gastroenterology (Gastroenterology ) Vol: 159 Issue: 3 Pages: 944-955.e8 Pub: 2020 Sep ePub: 2020 May 20 Authors Zuo T,Zhang F,Lui GCY,Yeoh YK,Li AYL,Zhan H,Wan Y,Chung ACK,Cheung CP,Chen N,Lai CKC,Chen Z,Tso EYK,Fung KSC,Chan V,Ling L,Joynt G,Hui DSC,Chan FKL,Chan PKS,Ng SC |
| 3 | 📚 |
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions.
Signal transduction and targeted therapy (Signal Transduct Target Ther ) Vol: 7 Issue: 1 Pages: 143 Pub: 2022 Apr 29 ePub: 2022 Apr 29 Authors Wang B,Zhang L,Wang Y,Dai T,Qin Z,Zhou F,Zhang L |
| 4 | 📚 |
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19.
Frontiers in medicine (Front Med (Lausanne) ) Vol: 7 Issue: Pages: 389 Pub: 2020 ePub: 2020 Jul 7 Authors d`Ettorre G,Ceccarelli G,Marazzato M,Campagna G,Pinacchio C,Alessandri F,Ruberto F,Rossi G,Celani L,Scagnolari C,Mastropietro C,Trinchieri V,Recchia GE,Mauro V,Antonelli G,Pugliese F,Mastroianni CM |
| 5 | 📚 |
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.
Gut (Gut ) Vol: Issue: Pages: Pub: 2022 Jan 26 ePub: 2022 Jan 26 Authors Liu Q,Mak JWY,Su Q,Yeoh YK,Lui GC,Ng SSS,Zhang F,Li AYL,Lu W,Hui DS,Chan PK,Chan FKL,Ng SC |
| 6 | 📚 |
Gut microbiota in COVID-19: new insights from inside.
Gut microbes (Gut Microbes ) Vol: 15 Issue: 1 Pages: 2201157 Pub: 2023 Jan-Dec ePub: Authors Zhou B,Pang X,Wu J,Liu T,Wang B,Cao H |
| 7 | 📚 |
Gut Microbiota Interplay With COVID-19 Reveals Links to Host Lipid Metabolism Among Middle Eastern Populations.
Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue: Pages: 761067 Pub: 2021 ePub: 2021 Nov 5 Authors Al Bataineh MT,Henschel A,Mousa M,Daou M,Waasia F,Kannout H,Khalili M,Kayasseh MA,Alkhajeh A,Uddin M,Alkaabi N,Tay GK,Feng SF,Yousef AF,Alsafar HS |
| 8 | 📚 |
Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery.
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue: Pages: 638825 Pub: 2021 ePub: 2021 May 13 Authors Tian Y,Sun KY,Meng TQ,Ye Z,Guo SM,Li ZM,Xiong CL,Yin Y,Li HG,Zhou LQ |
| 9 | 📚 |
Integrated analysis of gut microbiome and host immune responses in COVID-19.
Frontiers of medicine (Front Med ) Vol: 16 Issue: 2 Pages: 263-275 Pub: 2022 Apr ePub: 2022 Mar 8 Authors Xu X,Zhang W,Guo M,Xiao C,Fu Z,Yu S,Jiang L,Wang S,Ling Y,Liu F,Tan Y,Chen S |
| 10 | 📚 |
It Ain`t Over `Til It`s Over: SARS CoV-2 and Post-infectious Gastrointestinal Dysmotility.
Digestive diseases and sciences (Dig Dis Sci ) Vol: Issue: Pages: Pub: 2022 Mar 30 ePub: 2022 Mar 30 Authors Coles MJ,Masood M,Crowley MM,Hudgi A,Okereke C,Klein J |
| 11 | 📚 |
Missing microbes in infants and children in the COVID-19 pandemic: a study of 1,126 participants in Beijing, China.
Science China. Life sciences (Sci China Life Sci ) Vol: 67 Issue: 8 Pages: 1739-1750 Pub: 2024 Aug ePub: 2024 May 9 Authors Wang J,Li Y,Mu Y,Huang K,Li D,Lan C,Cui Y,Wang J |
| 12 | 📚 |
Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome.
Nature communications (Nat Commun ) Vol: 13 Issue: 1 Pages: 6806 Pub: 2022 Nov 10 ePub: 2022 Nov 10 Authors Liu Q,Su Q,Zhang F,Tun HM,Mak JWY,Lui GC,Ng SSS,Ching JYL,Li A,Lu W,Liu C,Cheung CP,Hui DSC,Chan PKS,Chan FKL,Ng SC |
| 13 | 📚 |
Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
Life sciences (Life Sci ) Vol: Issue: Pages: 122136 Pub: 2023 Sep 30 ePub: 2023 Sep 30 Authors Krasaewes K,Chaiwarith R,Chattipakorn N,Chattipakorn SC |
| 14 | 📚 |
Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.
Journal of internal medicine (J Intern Med ) Vol: 291 Issue: 6 Pages: 801-812 Pub: 2022 Jun ePub: 2022 Mar 17 Authors Vestad B,Ueland T,Lerum TV,Dahl TB,Holm K,Barratt-Due A,Kåsine T,Dyrhol-Riise AM,Stiksrud B,Tonby K,Hoel H,Olsen IC,Henriksen KN,Tveita A,Manotheepan R,Haugli M,Eiken R,Berg Å,Halvorsen B,Lekva T,Ranheim T,Michelsen AE,Kildal AB,Johannessen A,Thoresen L,Skudal H,Kittang BR,Olsen RB,Ystrøm CM,Skei NV,Hannula R,Aballi S,Kvåle R,Skjønsberg OH,Aukrust P,Hov JR,Trøseid M,NOR-Solidarity study group. |
| 15 | 📚 |
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study.
Microorganisms (Microorganisms ) Vol: 9 Issue: 6 Pages: Pub: 2021 Jun 7 ePub: 2021 Jun 7 Authors Kim HN,Joo EJ,Lee CW,Ahn KS,Kim HL,Park DI,Park SK |
| 16 | 📚 |
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Gut microbes (Gut Microbes ) Vol: 13 Issue: 1 Pages: 1-15 Pub: 2021 Jan-Dec ePub: Authors Newsome RC,Gauthier J,Hernandez MC,Abraham GE,Robinson TO,Williams HB,Sloan M,Owings A,Laird H,Christian T,Pride Y,Wilson KJ,Hasan M,Parker A,Senitko M,Glover SC,Gharaibeh RZ,Jobin C |
| 17 | 📚 |
Tropheryma whipplei infection in the lung of a patient with long COVID: a case report.
BMC infectious diseases (BMC Infect Dis ) Vol: 24 Issue: 1 Pages: 292 Pub: 2024 Mar 6 ePub: 2024 Mar 6 Authors Ruan W,Xu J,Yang F,Wu X,Ying K |
The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.
| 18 | 📚 |
Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues.
Pharmacological research (Pharmacol Res ) Vol: 160 Issue: Pages: 105085 Pub: 2020 Jul 16 ePub: 2020 Jul 16 Authors Mandal SK,Maji AK,Mishra SK,Ishfaq PM,Devkota HP,Silva AS,Das N |
| 19 | 📚 |
Long COVID and its Management.
International journal of biological sciences (Int J Biol Sci ) Vol: 18 Issue: 12 Pages: 4768-4780 Pub: 2022 ePub: 2022 Jul 11 Authors Koc HC,Xiao J,Liu W,Li Y,Chen G |
| 20 | 📚 |
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.
Diseases (Basel, Switzerland) (Diseases ) Vol: 12 Issue: 5 Pages: Pub: 2024 May 6 ePub: 2024 May 6 Authors Calcaterra V,Zanelli S,Foppiani A,Verduci E,Benatti B,Bollina R,Bombaci F,Brucato A,Cammarata S,Calabrò E,Cirnigliaro G,Della Torre S,Dell`osso B,Moltrasio C,Marzano AV,Nostro C,Romagnuolo M,Trotta L,Savasi V,Smiroldo V,Zuccotti G |
| 21 | 📚 |
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.
BMJ open (BMJ Open ) Vol: 14 Issue: 5 Pages: e085272 Pub: 2024 May 13 ePub: 2024 May 13 Authors Naik H,Cooke E,Boulter T,Dyer R,Bone JN,Tsai M,Cristobal J,McKay RJ,Song X,Nacul L |
| 22 | 📚 |
Low-dose Naltrexone Improves post-COVID-19 condition Symptoms.
Clinical therapeutics (Clin Ther ) Vol: 46 Issue: 3 Pages: e101-e106 Pub: 2024 Mar ePub: 2024 Jan 23 Authors Tamariz L,Bast E,Klimas N,Palacio A |
| 23 | 📚 |
Potential Anti-Inflammatory and Anti-Fatigue Effects of an Oral Food Supplement in Long COVID Patients.
Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 17 Issue: 4 Pages: Pub: 2024 Apr 5 ePub: 2024 Apr 5 Authors Noce A,Marrone G,Di Lauro M,Vita C,Montalto G,Giorgino G,Chiaramonte C,D'Agostini C,Bernardini S,Pieri M |
| 24 | 📚 |
Role of nutrient supplements in children with post-COVID condition: a retrospective preliminary observation and narrative review.
Italian journal of pediatrics (Ital J Pediatr ) Vol: 51 Issue: 1 Pages: 119 Pub: 2025 Apr 16 ePub: 2025 Apr 16 Authors Morello R,De Rose C,Martino L,Raffaelli F,Zampino G,Valentini P,Buonsenso D |
The following items have been cited in the above studies
| ID | Studies | Name | AKA |
|---|---|---|---|
| 204 | 1 | (RS)-2-(4-(2-methylpropyl)phenyl)propanoic acid {ibuprofen} | Advil, Motrin, Nurofen, Brufen |
| 25 | 1 | acetylsalicylic acid,aspirin | acetylsalicylsalicylic acid non-drug |
| 316 | 1 | alpha-linolenic acid {Omega-3} | ALA. Plant based, Flaxseed, otherwise see Fish oil NOT a-Lipoic acid (also ALA) |
| 1864 | 1 | ascorbic acid {Vitamin C} | |
| 1871 | 1 | Decoction of Four Noble Drugs {Sijunzi Decoction (SJZD)} | Sijunzi Tang, Mixture of Radix Ginseng, Poria, Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae |
| 2862 | 1 | Echinacea Moench {Echinacea} | Coneflower, Purple coneflower, American coneflower |
| 1246 | 1 | indomethacin,(prescription) | |
| 4568 | 1 | Lactotransferrin {Lactoferrin} | Transferrin,Conalbumin,Ovotransferrin, Growth-inhibiting protein 12 |
| 1033 | 2 | naltrexone hydrochloride dihydrate,(prescription) LDN | Low dosage naltrexone, (abernil, adepend, nalerona, naltrexone, naltrexone accord, naltrexone accord healthcare, naltrexone aop, neksi, vivitrol, anarcol, antaxon, antaxone, contrave, dependex, destoxican, embeda, ethylex, nalorex, naltax, naltraccord, naltrax, naltrexin, naltrexon accord, naltrexon aop, naltrexon hcl aop, naltrexon hcl sandoz, naltrexon hexal, naltrexon hydrochloride accord, naltrexon vitaflo, naltrexona accord, naltrexona destoxican, naltrexona wynn, naltrexone generichealth, naltrexone hcl l.molteni, naltrexone hydrochloride accord, naltrexone hydrochloride accord healthcare, naltrexone hydrochloride aop, naltrexone hydrochloride intas, naltrexone intas pharmaceuticals, naltrexone mylan, naltrexone orphan, naltrexone poa pharma, naltrexon-hci neuraxpharm, naltrexonhydrochloride pch, naltrexon-neuraxpharm, narcoral, nemexin, nuo xin sheng, nutrexon, phaltrexia, revez, revia, trexonil) |
| 2961 | 1 | Panax ... {Ginseng} | Asian or Korean ginseng,American ginseng,Renshen,Baiguo |
| 1460 | 1 | prednisone,(prescription) | |
| 343 | 1 | Propolis {Bee glue} | Acide de Cire d'Abeille,Baume de Propolis |
| 364 | 1 | Rosa canina {Rosehip} | Briar rose,Common briar,Cynorrhodon, |
| 441 | 1 | Zinc {Zinc Supplements} | Zinc sulfate,Zinc acetate,Zinc gluconate,Zinc picolinate,Zinc citrate,Zinc oxide,Zinc monomethionine |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
